How many insider declarations does 海森药业 have?

海森药业 has filed 1 insider declaration with AMF.

Who is the top reporting insider at 海森药业?

The top reporting insider at 海森药业 is 胡康康, based on the count of public filings.

What is the net insider buy vs sell volume on 海森药业?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

海森药业: management transactions · France · AMF

SZSE:001367FR·AMFMcap 3.3Bn€

AMF ↗

Browse the full directors' dealings record of 海森药业, a publicly traded company based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €3.3bn. The latest transaction was reported on 30 December 2025 (Sale). Among the most active insiders: 胡康康. The full history is free.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

1 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

23.33 €

Income statement

Revenue532.3 M€

Gross profit242.7 M€46% margin

Net income135.9 M€25.5% margin

Balance sheet & cash

Market cap3.34 Bn€

Total debt7.4 M€

Free Cash Flow25.2 M€

Last declaration on 30 December 2025

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations